In June of 2013, 45 year old Teodora Palmieri-Chuck was found dead in a New Zealand clinic after undergoing an experimental treatment for opiate addiction. The Italian woman, who immigrated to New Zealand in her early teens, suffered from an addiction to morphine for over two decades before seeking treatment through Te Whare Rongoa (House of Medicine), where the General Practitioner, Cornelius Van Dorp, determined she was a suitable patient for a 12-month, experimental study on the effects of ibogaine.
According to The New Zealand Herald, Palmieri-Chuck received five doses over a two day period before being discovered deceased early on the morning of the third day. Dr. Van Dorp administered four doses on the first day of treatment and the final dose on the second day before departing on an overseas trip, leaving the patient under the care of his wife and assistant, Anah Van Dorp.
The New Zealand Herald and the New Zealand Doctor Newspaper describes ibogaine as a psychoactive drug, derived from the roots of a West African shrub and considered a rapid-detox drug, as ibogaine interacts with several neurotransmitters in the central nervous system.
Illegal in the US, France, Denmark, Sweden, Belgium, Switzerland, and Australia but largely unregulated in other countries, the drug is used to suppress the symptoms of withdrawal; however, while low doses act as a stimulant, high doses of ibogaine causes hallucinations. Ibogaine users experience a dream-like state within the first few hours after administration which lasts four to eight hours, followed by a “personal reflective period” lasting between 8 to 20 hours with residual effects of the drug lasting up to 72 hours.
The drug is unapproved in New Zealand but classified as a prescription drug for study purposes and to discourage self-medication. Dr. Van Dorp neglected to provide sufficient information on the risks and side effects of ibogaine use, as well as forwent to properly document Palmieri-Chuck’s consent to treatment and monitoring of the experimental treatment, resulting in a breach of New Zealand’s Code of Health and Disabilities Services Consumer Rights.
As a result, the general practitioner no longer practices in New Zealand and has agreed to receive further training before resuming his practice. He and his wife issued a personal apology to the family of the deceased woman. Iboga New Zealand Limited, the suppliers of the ibogaine that killed Teodora Palmieri-Chuck, has also been held responsible for the breach in Health Code and organizational failings.
Keep Up With Trending Addiction News
Follow us: Facebook | Twitter | Google+ |Pinterest | Instagram
The post New Zealand Practitioner Orders Unregulated Ibogaine Treatment, Patient Suffers Fatal Overdose appeared first on Harbor Village Florida.
from Misc http://ift.tt/1L4j7mi via Heroin Rehab Dallas
No comments:
Post a Comment